Navigation Links
New Clinical Trial Review: Leukemia Patients Treated by Bellicum Pharmaceuticals -- 91% remission, 94% Survival (median follow-up 301 Days) Source: Pluvia Research
Date:4/10/2017

April 10, 2017, a new clinical trial report released today compares the significance of historic results treating Acute Leukemia patients vs clinical trial data reported by Bellicum Pharmaceuticals (NASDAQ: BLCM). The clinical trial review was released by Pluvia Securities Research (PSR).

The report reviews data from 122 malignant and non-malignant patients treated with BPX-501 (Bellicum Pharmaceuticals, clinical trial identifier NCT01865617 & NCT02065869). Leukemia patients treated by Bellicum, (n=35) had an overall survival rate of 94% at 6 months compared to a historical 6 month leukemia survival rate of 78% (source: National Donor Marrow Program)

56 patients with non-malignant blood disorders are also treated in the Bellicum trial. These include patients with Sickle Cell disease, Thalassemia Major and Wiscott-Aldrich. The report issued by PSR compares historical survival of these diseases at 1yr (82-92%) with 100% survival of patients treated by Bellicum BPX-501.

The full PSR Clinical Trial Review of Bellicum BPX-501 is available for free download (here)

For Additional Information Contact:
Steve Pluvia
Pluvia Research
801.824.1549

Read the full story at http://www.prweb.com/releases/2017/04/prweb14229071.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Allegheny Health Network Clinical Trial Examines Regorafenib as Maintenance Therapy for Colon Cancer
2. DrugDev Thought Leaders Share Experience and Insights on How Transformative Technology Improves Clinical Trials at Premier Pharma and Biotech Industry Conferences in Q2
3. Catalent Expands Kansas City Clinical Storage and Secondary Packaging Capabilities to Meet Growing Demand for Cold Chain Services
4. New DrugDev Educational Webinar Reveals How Biotechs and Smaller Pharmaceutical Companies Gain Site Attention and Engagement by Optimizing Clinical Trial Payments
5. FDAnews Announces — Medical Device Clinical Evaluation Reports: Complying with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance Webinar, April 4, 2017
6. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
7. Intrinsic Imaging Awarded Phase II Immuno-Oncology Clinical Trial for the Treatment of Non-Small Cell Lung Cancer and Small Cell Lung Cancer
8. Challenges and Innovation in Clinical Trial Supply to be Presented by Catalent Experts at Upcoming Conferences
9. Peanut Patch Continues to Show Promise in Extension of Latest Clinical Trial
10. New Clinical Data on Cryoablation For The Treatment Of Early Stage Breast Cancer To Be Presented At Susan G. Komen San Diego
11. ERT Clinical Trial Oversight Selected by Premier Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2018)... NEW YORK (PRWEB) , ... October 18, 2018 ... ... services that include primary care, cancer and hematology, and a comprehensive Women’s Center, ... 80,000 square foot health complex at 5 Cuba Hill Road in Greenlawn, Suffolk ...
(Date:10/17/2018)... ... ... Power to Decide, the campaign to prevent unplanned pregnancy, announced the launch of ... from the HHS Office of Adolescent Health, Innovation Next is a unique accelerator program ... technology-enabled ideas. , This year, five new teams will be selected to participate in ...
(Date:10/16/2018)... (PRWEB) , ... October 16, 2018 , ... ... specializes in small business loans, equipment leasing, and franchise financing , is ... throughout the United States. Balboa Capital will structure and deliver custom-tailored financing programs ...
(Date:10/16/2018)... Va. (PRWEB) , ... October 16, 2018 , ... ... Oct. 23-25, 2018 – Bethesda, MD, http://www.fdanews.com/fdainspectionssummit , The 13th Annual ... last year’s Inspections Summit that it sometimes feels difficult to keep up. The ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... research networking-technology company founded by patient-survivors, and The Avoca Group, Inc., a ... clinical trial execution process, today announced its mutual collaboration that will make ...
Breaking Medicine News(10 mins):
(Date:10/16/2018)... ... October 16, 2018 , ... Censis Technologies announced today that ... tracking software company. Censis is the leader in the surgical inventory management space ... using their strong portfolio of solutions, including CensiTrac, LoanerLink, and ScopeTrac. , ...
(Date:10/16/2018)... ... ... Ripple Massage, Australia’s leading mobile massage company, has added to ... soaks to its packages. , “Ripple is much more than a mobile massage service,” ... all the pampering extras when they book a massage with us that can turn ...
(Date:10/16/2018)... ... 16, 2018 , ... The iaedp™ Foundation, recognized for excellence ... treatment providers who treat the full spectrum of eating disorder problems, will once ... track at Symposium 2019. The courses are regularly offered in a self-paced, ...
Breaking Medicine Technology: